DUBLIN--(BUSINESS WIRE)--Nov. 13, 2013--
plc (NYSE: MNK), a global specialty pharmaceutical and global medical
imaging company, will present at the Jefferies 2013 Global Healthcare
Conference in London on Wednesday, November 20, 2013. Mark Trudeau,
President and Chief Executive Officer of Mallinckrodt, will represent
the company in a session scheduled to begin at 9:20 am London Time. The
meeting will be held at the Waldorf Hilton in London.
Individuals who are unable to attend the meeting in person will be able
to view a live video and webcast at: http://mallinckrodt.com/investor_relations.
A replay of the presentation will be available on the website for 14
days following the conclusion of the meeting. Mallinckrodt will also
have the presentation materials posted on the company’s website.
Mallinckrodt is a global specialty pharmaceutical and medical imaging
business that develops, manufactures, markets and distributes specialty
pharmaceutical products and medical imaging agents. The company’s
Specialty Pharmaceuticals segment includes branded and generic drugs and
active pharmaceutical ingredients, and the Global Medical Imaging
segment includes contrast media and nuclear imaging agents. Mallinckrodt
has approximately 5,500 employees worldwide and a commercial presence in
roughly 70 countries. The company’s 2013 revenue totaled $2.2 billion.
To learn more about Mallinckrodt, visit www.mallinckrodt.com.
John Moten, 314-654-6650
Vice President, Investor
Manager, Media Relations